Course Preamble | POWER-PAK C.E.®

Pharmacy Technician

PTCB Recertification and State Required CE

START NOW

Pharmacist

Pharmacists Library

All the CE you need for 1 year to meet state requirements just $97.00.

START NOW
oatph

Incorporating Advancements in Monoclonal Antibody Therapeutics into Patient Management Strategies within Dyslipidemia

Jointly provided by Postgraduate Institute for Medicine and AcademicCME.
    

This activity is supported by an independent educational grant from Sanofi US and Regeneron Pharmaceuticals Alliance.

Release Date

March 24, 2015

Valid for credit through

March 31, 2016

Estimated Time to Complete Activity:

30 minutes per activity for a total of 1.5 hours

TARGET AUDIENCE

Cardiologists, internists, primary care physicians, RNs, NPs, PAs, pharmacists, and other healthcare professionals who care for patients with dyslipidemia.

STATEMENT OF NEED/PROGRAM OVERVIEW

This CME/CE program addresses scientific advancements in monoclonal antibody therapy and the management of patients with dyslipidemia. The unique educational format of this initiative includes a learner driven, interactive, on-demand, webcast structured as three 20-minute modules that will each be delivered using the unique ArcheMedX Platform. This program aims to arm health care providers with information on disease management, diagnosis, and emergent clinical trial data in order to improve the care administered to patients with dyslipidemia. The interactive set-up of this CME program will provide an optimal learner experience, resulting in greater quality care for patients in practice.

Faculty

Christopher Cannon, MD
Cardiovascular Medicine
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School                                      
Boston, MA

Peter P. Toth, MD, PhD
Director of Preventative Cardiology
CGH Medical Center
Clinical Professor
University of Illinois College of Medicine
Peoria, IL

Michael J. Koren, MD
CEO, Jacksonville Center for Clinical Research
Past President, Academy of Physicians in Clinical Research
Jacksonville, FL

Robert S. Rosenson, MD
Professor of Medicine
Director of Cardiometabolic Disorders
Icahn School of Medicine at Mount Sinai
New York, NY

Accreditation

0.50 AMA PRA Category 1 Credit(s)TM  for physicians, per module
0.5 contact hours for pharmacists (0.05 CEUs), per module
0.4 and 0.3 contact hours for nurses (module 1 and 2, 0.4 CE's; module 3, 0.3 CE's)

Activities


Module 1:

Guidelines, New Options for LDL Management, and Statin Intolerance
Module 2:

Clinical Trial Targeting PCSK9 for Treatment of Hyperlipidemia
Module 3:

Applying Monoclonal Antibodies with Statin Therapy to Optimize Patient Outcomes
 

Postgraduate Healthcare Education, LLC (PHE) is the source of Power-Pak C.E.® continuing education for health care professionals. Our accredited programs assist in meeting the requirements of licensure. PHE provides continuing education for the broad spectrum of health care professionals. This site features a searchable database of accredited Power-Pak C.E.® courses on important topics for today's health care professionals.

PHE customizes Power-Pak C.E.® online for each visitor by creating a personal participant profile. Registered participants may update their contact information, take an exam, receive instant grading, view their exam history, and print certificates for successfully completed programs at any time. Monthly notifications will be sent to participants notifying you of new courses available on the site.